Unbiased AI-powered news
1 stories related to this topic, newest first.
The U.S. Food and Drug Administration proposed withdrawing approval for Amgen's drug Tavneos on April 28, 2026, citing lack of proven effectiveness and false statements in the original application. The agency reported 76 cases of drug-induced liver injury linked to the drug, incl…